Montelukast for Prevention & Treatment of OHSS

Montelukast for Prevention & Treatment of Ovarian Hyperstimulation Syndrome in Freeze-all Cycles

montelukast & dydrgesteron will be given to cases with suspected or proven ovarian hyperstimulation in one group in comparison with dydrogesteron alone in the other group.

patients with high risk for ovarian hyperstimulation will undergo a freeze-all protocol then montelukast & dydrgesteron will be given to cases with suspected or proven ovarian hyperstimulation in one group in comparison with dydrogesteron alone in the other group.

Inclusion Criteria:

• PCOS high responders high numbers of ovum retrieved

Exclusion Criteria:

• hypersensitivity to any drug components phenylketonuria patients depression liver dysfunction